Association of Increased Hepatitis C Virus (HCV)–Specific IgG and Soluble CD26 Dipeptidyl Peptidase IV Enzyme Activity with Hepatotoxicity after Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus–HCV‐Coinfected Patients-Reference-Cited by-同舟云学术

Association of Increased Hepatitis C Virus (HCV)–Specific IgG and Soluble CD26 Dipeptidyl Peptidase IV Enzyme Activity with Hepatotoxicity after Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus–HCV‐Coinfected Patients

Published:2002-11-15 Issue:10 Volume:186 Page:1498-1502
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:J INFECT DIS

Author:

Stone Shelley F.,Lee Silvia,Keane Niamh M.,Price Patricia,French Martyn A.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/186/10/1498/18006808/186-10-1498.pdf

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PRE1BRAZIL Protocol: A Randomized Controlled Trial to Evaluate the Effectiveness and Safety of the DPP-4 Inhibitor Alogliptin in Delaying the Progression of Stage 2 Type 1 Diabetes;Diabetes, Metabolic Syndrome and Obesity;2024-02

2. Potential Effect of DPP-4 Inhibitors Towards Hepatic Diseases and Associated Glucose Intolerance;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2022-06

3. Influence of IL28B gene polymorphisms on PegINF-RBV-mediated HCV clearance in HIV-HCV co-infected patients: A meta-analysis;Meta Gene;2021-09

4. Emerging Roles of Dipeptidyl Peptidase-4 Inhibitors in Delaying the Progression of Type 1 Diabetes Mellitus;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2021-02

5. The dynamics of HCV-specific antibody responses in HIV/HCV patients on long-term antiretroviral therapy;Clinical Immunology;2017-06